MSD to Acquire Verona Pharma for $10 Billion, Expanding Respiratory Portfolio
In a landmark deal poised to reshape the respiratory disease treatment landscap US pharmaceutical giant...
Deals
Adagene Collaborates with ConjugateBio to Develop Bispecific Antibody Drug Conjugates
China-based Adagene Inc. (NASDAQ: ADAG) announced a strategic collaboration with US-headquartered biotech ConjugateBio Inc. to...
Zhaoke Ophthalmology Partners with Somerset Therapeutics to Accelerate US Expansion
China-based Zhaoke Ophthalmology Ltd (HKG: 6622) announced last month a strategic partnership with US generic...
LakeShore Biopharma Secures $15 Million in Private Placement to Fuel Growth
China-based biopharmaceutical company LakeShore Biopharma Co., Ltd (NASDAQ: LSB) has announced the successful execution of...
NK CellTech Secures $14 Million in Series A+++ Financing to Advance NK Cell Therapies
China-based biotech innovator NK CellTech has successfully closed its Series A+++ financing round, raising RMB...
Shenzhen Concemed Medtech Secures Hundreds of Millions in Series A+ Funding for Endoscopy Expansion
Shenzhen Concemed Medical Technology Co., Ltd., a China-based endoscope specialist, has reportedly secured “hundreds of...
GSK Completes Acquisition of Boston Pharma’s BP Asset IX for Efimosfermin Alpha
UK-based GlaxoSmithKline (GSK; NYSE: GSK) announced the completion of its acquisition of BP Asset IX, a...
Qilu Pharmaceutical Partners with Sagent Pharmaceuticals to Expand US Market Presence
China-based Qilu Pharmaceutical Co., Ltd. this week announced a strategic partnership with US-headquartered Sagent Pharmaceuticals....
Roche’s Chugai Pharmaceutical Partners with Gero to Develop Therapies for Age-Related Diseases
Roche’s Japan-based subsidiary Chugai Pharmaceutical Co., Ltd. (TYO: 4519) announced this week a joint research...
CStone Pharmaceuticals Licenses Cejemly to Istituto Gentili for 23 Countries in Europe and the UK
China-based CStone Pharmaceuticals (HKG: 2616) announced a licensing agreement with Istituto Gentili S.R.L., granting the...
Modella AI Collaborates with AstraZeneca to Accelerate Oncology Drug Development with AI
US-based Modella AI, a leader in biomedical artificial intelligence (AI), announced a multi-year collaboration with...
Micot Raises Over RMB 100 Million in Series D Funding Led by Zheshang Venture Capital
Micot, a polypeptide new molecular entity (NME) drug developer with operations in mainland China, Hong...
AstraZeneca in Talks for $15B Licensing Deal for Ivonescimab with Summit Therapeutics
UK-based AstraZeneca plc (AZ, NASDAQ: AZN) is reportedly in negotiations with Summit Therapeutics, the US...
China’s WeiMai Plans Hong Kong IPO to Expand AI-Powered Healthcare Services
China-based WeiMai Inc. plans to make an initial public offering (IPO) to the Hong Kong...
BioVersys Partners with Shionogi to Advance BV500 for Non-Tuberculous Mycobacterial Infections
Swiss biopharma BioVersys AG (SWX: BIOV) announced a research and exclusive license option agreement with...
Fosun Pharma Subsidiary Launches Co-Developed Biochemical Reagent with Siemens Healthineers
Shanghai Fosun Pharmaceutical (Group) Co., Ltd’s (SHA: 600196, HKG: 2196) subsidiary Fosun Diagnostics (Shanghai) Co.,...
CR Medical Holdings Partners with Shanghai Haohai Bio in Medical Aesthetics Sector
China Resources Medical Holdings Company Limited has entered into a strategic partnership with Shanghai Haohai...
Brii Biosciences Licenses BRII-693 to Joincare Pharma for Development in Greater China
China-based Brii Biosciences Ltd (HKG: 2137) announced a licensing agreement with compatriot firm Joincare Pharmaceutical...
AstraZeneca CEO Soriot Explores US Stock Listing Move, Potentially Impacting London Exchange
AstraZeneca (AZ, NASDAQ: AZN) CEO Pascal Soriot is exploring plans to move the British pharmaceutical...
Sun-Novo Pharma Collaborates with LeKuang Huilin on STC007 for Post-Abdominal Surgery Pain
China-based Beijing Sun-Novo Pharmaceutical Research Co., Ltd (SHA: 688621) this week entered into a technology...